EP0901476A4 - Aryloxy- und arylthio-verknüpfte Pyridine und Pyrimidine, sowie Derivate davon - Google Patents
Aryloxy- und arylthio-verknüpfte Pyridine und Pyrimidine, sowie Derivate davonInfo
- Publication number
- EP0901476A4 EP0901476A4 EP97916985A EP97916985A EP0901476A4 EP 0901476 A4 EP0901476 A4 EP 0901476A4 EP 97916985 A EP97916985 A EP 97916985A EP 97916985 A EP97916985 A EP 97916985A EP 0901476 A4 EP0901476 A4 EP 0901476A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pyrimidines
- arylthio
- aryloxy
- derivatives
- fused pyridines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1409096P | 1996-03-26 | 1996-03-26 | |
US14090P | 1996-03-26 | ||
US64661196A | 1996-05-08 | 1996-05-08 | |
US646611 | 1996-05-08 | ||
PCT/US1997/004828 WO1997035846A1 (en) | 1996-03-26 | 1997-03-25 | Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0901476A1 EP0901476A1 (de) | 1999-03-17 |
EP0901476A4 true EP0901476A4 (de) | 2001-08-16 |
Family
ID=26685647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97916985A Withdrawn EP0901476A4 (de) | 1996-03-26 | 1997-03-25 | Aryloxy- und arylthio-verknüpfte Pyridine und Pyrimidine, sowie Derivate davon |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0901476A4 (de) |
JP (1) | JP2000507552A (de) |
AU (1) | AU725254B2 (de) |
CA (1) | CA2249598A1 (de) |
NZ (1) | NZ331647A (de) |
WO (1) | WO1997035846A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
PT1129096E (pt) | 1998-11-12 | 2003-09-30 | Neurocrine Biosciences Inc | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos |
JP2002529465A (ja) | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ, インコーポレイテッド | Crfレセプターアンタゴニストおよびcrfレセプターアンタゴニストに関する方法 |
US6432989B1 (en) | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
HUP0301801A2 (hu) * | 2000-07-14 | 2003-09-29 | Bristol-Myers Squibb Pharma Company | Imidazo[1,2-a]pirazin-származékok és az ezeket tartalmazó gyógyszerkészítmények |
MXPA03008185A (es) | 2001-03-13 | 2004-01-29 | Bristol Myers Squibb Pharma Co | 4-(2-butilamino)-2, 7-dimetil-8 -(2-metil-6-metoxipirid -3-il) pirazol-[1, 5-a]-1, 3, 5-triazina, sus enantiomeros y sales farmaceuticamente aceptables como ligandos del receptor del factor de liberacion de corticotropina. |
PL366577A1 (en) | 2001-05-14 | 2005-02-07 | Bristol-Myers Squibb Pharma Company | Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
AU2002354575A1 (en) | 2001-07-12 | 2003-01-29 | Bristol-Myers Squibb Pharma Company | Tetrahydropurinones as corticotropin releasing factor |
WO2003006015A1 (en) | 2001-07-13 | 2003-01-23 | Bristol-Myers Squibb Pharma Company | Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
US20030119831A1 (en) | 2001-11-20 | 2003-06-26 | Hartz Richard A. | 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands |
GB0219746D0 (en) * | 2002-08-23 | 2002-10-02 | Inst Of Ex Botany Ascr | Azapurine derivatives |
KR20210061202A (ko) * | 2019-11-19 | 2021-05-27 | 일동제약(주) | 벤조나이트릴이 치환된 축합 피리미딘 유도체 및 그의 의약 용도 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076711A (en) * | 1976-04-05 | 1978-02-28 | Schering Corporation | Triazolo [4,5-d]-pyrimidines |
JPS56131587A (en) * | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | 7-substituted triazolopyrimidine derivative and its preparation |
JPS5962595A (ja) * | 1982-09-30 | 1984-04-10 | Ss Pharmaceut Co Ltd | 3,5,7―トリ置換―トリアゾロピリミジン誘導体 |
EP0298467A2 (de) * | 1987-07-10 | 1989-01-11 | Hoechst Aktiengesellschaft | In 6- und 9-Stellung substituierte 2-Amino-8-aza-purine, ihre Verwendung, diese Purine enthaltende Arzneimittel und Verfahren zur Herstellung der Purine |
EP0458519A2 (de) * | 1990-05-24 | 1991-11-27 | Efamol Holdings Plc | Synthese von Nukleotid- und Nukleosidderivaten |
US5075445A (en) * | 1983-08-18 | 1991-12-24 | Beecham Group P.L.C. | Guanine derivatives |
WO1994013677A1 (en) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrazolopyrimidines as crf antagonists |
WO1994013676A1 (en) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrrolopyrimidines as crf antagonists |
WO1995010506A1 (en) * | 1993-10-12 | 1995-04-20 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
EP0664294A1 (de) * | 1994-01-19 | 1995-07-26 | Colin Reese | Herstellung von Nucleoside-Analogen |
WO1995033750A1 (en) * | 1994-06-08 | 1995-12-14 | Pfizer Inc. | Corticotropin releasing factor antagonists |
WO1995033727A1 (en) * | 1994-06-06 | 1995-12-14 | Pfizer Inc. | Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
WO1995034563A1 (en) * | 1994-06-16 | 1995-12-21 | Pfizer Inc. | Pyrazolo and pyrrolopyridines |
EP0778277A1 (de) * | 1995-12-08 | 1997-06-11 | Pfizer Inc. | Substitutierte heterozyclische Derivate als CRF Antagonisten |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56131586A (en) * | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | Triazolopyrimidine derivative and its preparation |
US4916224A (en) * | 1988-01-20 | 1990-04-10 | Regents Of The University Of Minnesota | Dideoxycarbocyclic nucleosides |
-
1997
- 1997-03-25 CA CA002249598A patent/CA2249598A1/en not_active Abandoned
- 1997-03-25 EP EP97916985A patent/EP0901476A4/de not_active Withdrawn
- 1997-03-25 AU AU25453/97A patent/AU725254B2/en not_active Ceased
- 1997-03-25 NZ NZ331647A patent/NZ331647A/xx unknown
- 1997-03-25 WO PCT/US1997/004828 patent/WO1997035846A1/en not_active Application Discontinuation
- 1997-03-25 JP JP9534562A patent/JP2000507552A/ja active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076711A (en) * | 1976-04-05 | 1978-02-28 | Schering Corporation | Triazolo [4,5-d]-pyrimidines |
JPS56131587A (en) * | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | 7-substituted triazolopyrimidine derivative and its preparation |
JPS5962595A (ja) * | 1982-09-30 | 1984-04-10 | Ss Pharmaceut Co Ltd | 3,5,7―トリ置換―トリアゾロピリミジン誘導体 |
US5075445A (en) * | 1983-08-18 | 1991-12-24 | Beecham Group P.L.C. | Guanine derivatives |
EP0298467A2 (de) * | 1987-07-10 | 1989-01-11 | Hoechst Aktiengesellschaft | In 6- und 9-Stellung substituierte 2-Amino-8-aza-purine, ihre Verwendung, diese Purine enthaltende Arzneimittel und Verfahren zur Herstellung der Purine |
EP0458519A2 (de) * | 1990-05-24 | 1991-11-27 | Efamol Holdings Plc | Synthese von Nukleotid- und Nukleosidderivaten |
WO1994013677A1 (en) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrazolopyrimidines as crf antagonists |
WO1994013676A1 (en) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrrolopyrimidines as crf antagonists |
WO1995010506A1 (en) * | 1993-10-12 | 1995-04-20 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
EP0664294A1 (de) * | 1994-01-19 | 1995-07-26 | Colin Reese | Herstellung von Nucleoside-Analogen |
WO1995033727A1 (en) * | 1994-06-06 | 1995-12-14 | Pfizer Inc. | Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
WO1995033750A1 (en) * | 1994-06-08 | 1995-12-14 | Pfizer Inc. | Corticotropin releasing factor antagonists |
WO1995034563A1 (en) * | 1994-06-16 | 1995-12-21 | Pfizer Inc. | Pyrazolo and pyrrolopyridines |
EP0778277A1 (de) * | 1995-12-08 | 1997-06-11 | Pfizer Inc. | Substitutierte heterozyclische Derivate als CRF Antagonisten |
Non-Patent Citations (3)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 006, no. 007 (C - 087) 16 January 1982 (1982-01-16) * |
PATENT ABSTRACTS OF JAPAN vol. 008, no. 162 (C - 235) 26 July 1984 (1984-07-26) * |
See also references of WO9735846A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997035846A1 (en) | 1997-10-02 |
AU725254B2 (en) | 2000-10-12 |
JP2000507552A (ja) | 2000-06-20 |
AU2545397A (en) | 1997-10-17 |
EP0901476A1 (de) | 1999-03-17 |
CA2249598A1 (en) | 1997-10-02 |
NZ331647A (en) | 2000-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL335258A1 (en) | Arylamine-condensed pyridines and pyrimidines | |
ZA978452B (en) | Hetaroyl derivatives | |
ZA978451B (en) | Hetaroyl derivatives | |
ATE375344T1 (de) | Azolotriazine und pyrimidine | |
IL131521A0 (en) | Pyrimidine derivatives | |
PL336148A1 (en) | Nicotinamide derivatives | |
IL133904A0 (en) | Pyridine derivatives | |
GB9607729D0 (en) | Quinazoline derivatives | |
ZA971896B (en) | Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives | |
HK1026418A1 (en) | Novel pyrimidine derivatives and processes for the preparation thereof | |
SG71137A1 (en) | Thiouracil derivative | |
PL337645A1 (en) | Novel amidine derivatives and their application as thrombosin inhibitors | |
ZA972553B (en) | Aryloxy-and arylthio- substituted pyrimidines and triazines and derivatives thereof | |
GB9617322D0 (en) | Triazine derivatives and their use | |
PL330277A1 (en) | Derivatives of 2,4-diaminopyrimidine | |
EP0901476A4 (de) | Aryloxy- und arylthio-verknüpfte Pyridine und Pyrimidine, sowie Derivate davon | |
HK1025955A1 (en) | Novel pyrimidine derivative | |
HUP0001698A3 (en) | Substituted pyrimidine compounds and their use | |
HU9503012D0 (en) | New pyrimidine derivatives | |
IL123535A0 (en) | Benzoxazindione derivatives and their use | |
ZA985326B (en) | Aminospiropiperidine quinazoline derivatives | |
ZA981374B (en) | Pyridazin-3-one derivatives and their use | |
ZA9811565B (en) | Novel pyridine and pyrimidine derivatives | |
ZA981322B (en) | Pyridazin-3-one derivatives and their use | |
IL125904A0 (en) | Tetrahydropyrimidine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980914 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: OLSON, RICHARD, ERIC Inventor name: GILLIGAN, PAUL, JOSEPH Inventor name: BECK, JAMES, PETER Inventor name: BAKTHAVATCHALAM, RAJAGOPAL Inventor name: CHORVAT, ROBERT, JOHN Inventor name: RAJAGOPALAN, PARTHASARATHI |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07D 487/04 A, 7C 07D 471/04 B, 7C 07D 473/30 B, 7C 07D 473/00 B, 7C 07D 239/46 B, 7C 07D 239/48 B, 7A 61K 31/44 B, 7A 61K 31/505 B, 7A 61K 31/52 B, 7A 61K 31/53 B, 7C 07D 487/04 J, 7C 07D 249:00 J, 7C 07D 239:00 J, 7C 07D 487/04 K, 7C 07D 239:00 K, 7C 07D 231:00 K, 7C 07D 471/04 L, 7C 07D 235:00 L, 7C 07D 221:00 L, 7C 07D 471/04 M, 7C 07D 231:00 M, 7C 07D 221:00 M, 7C 07D 471/04 N, 7C 07D 249:00 N, 7C 07D 221:00 N |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010625 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BRISTOL-MYERS SQUIBB PHARMA COMPANY |
|
17Q | First examination report despatched |
Effective date: 20030930 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040211 |